Which sector has the biggest momentum heading into earnings season?

The ASX 200 also posted a healthy gain over the month.

| More on:
A group of people excitedly cheering at a horse race.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some Australian market sectors are performing stronger than others as we head further into earnings season.  

The S&P/ASX 200 Index (ASX: XJO) posted a healthy 2.4% gain in July, while the All Ordinaries Index (ASX: XAO) climbed 2.6% higher over the month, Macquarie Group Ltd (ASX: MQG) data reveals.

"Australian equities rose in July, with the ASX 200 up +2.4%. The key theme of the month was the rotation from leaders to laggards, a phenomenon that often occurs at the start of a new financial year," Macquarie said in a note to investors.

The S&P/ASX 200 Resources Index (ASX: XJR) gained 4.5% over the month.

"Resources (+4.5%) had a strong month, supported by a rise in commodity prices," Macquarie said.

The strength in Industrial resources was relatively broad, with strength across Iron Ore. Fortescue Ltd (ASX: FMG) shares gained 16%.

Lithium, oil & gas, and Coal increases also supported the monthly gains. Mineral Resources Ltd (ASX: MIN) shares climbed 33% and Pilbara Minerals Ltd (ASX: PLS) shares increased 20%. 

Woodside Energy Group Ltd (ASX: WDS) shares climbed 13% higher, and Whitehaven Coal Ltd (ASX: WHC) shares jumped 19%.

"Consistent with the strength in Resources, China's stocks outperformed +3.5%," the broker said.

Strongest momentum by sector

By sector, health came out on top as the clear winner. The S&P/ASX 200 Health Care Index (ASX: XHJ) climbed 8.7% over the course of July, drastically outpacing the benchmark

The sector's gains were driven by index heavyweight CSL Ltd (ASX: CSL) shares, which climbed 13%.

"[CSL] was likely a key beneficiary of investors shifting some large cap money out of banks," the broker note said. 

Pro Medicus Ltd (ASX: PME) and Resmed Inc (ASX: RMD) shares were also strong performers. The share prices increased by 13% and 8%, respectively.

The energy, technology, and utilities sectors came next in line. The S&P/ASX 200 Energy Index (ASX: XEJ) jumped 5.4% over the month. The S&P/ASX 200 Information Technology Index (ASX: XIJ) and S&P/ASX 200 Utilities Index (ASX: XUJ) climbed 5.2% and 5.1% higher, respectively.

The S&P/ASX 200 Materials Index (ASX: XMJ) climbed 4.1% in July, while the S&P/ASX 200 Real Estate Index (ASX: XRE) and the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) rose by 3.2% and 3%, respectively.

Industrials and communication services posted some gains over the course of the month, albeit at a lower level. The S&P/ASX 200 Industrials Index (ASX: XNJ) rose by 2.7% and the S&P/ASX 200 Communication Services Index (ASX: XTJ) increased by 2.2%. 

Meanwhile, the worst-performing ASX sector was financials, with the S&P/ASX 200 Financials Index (ASX: XFJ) falling 1%.

The second-worst sector was consumer staples, with the S&P/ASX 200 Consumer Staples Index (ASX: XSJ) posting a small 0.4% gain.

Macquarie's outlook

The broker said in its note to investors:

Our bottom-up FY25 EPSg forecast is a decline of 3.2%. If this proves correct, it will be the third year in a row of declining earnings. At this point, our team forecast a relatively weak EPSg rebound of +2.2% in FY26. Unfortunately, August is typically the peak month for downgrades, as conservative guidance re-sets the earnings bar lower. But driven by global rate cuts and economic momentum, we think Australia's economic activity will improve, and support earnings upgrades over FY26.

Seasonality outlook. After the positive returns that typically occur in July, the next two months are likely to be disappointing. Over the last decade, August has been the third worst for returns, while September is the worst (and usually negative). To the extent this negative seasonality plays out again in 2025, it would provide another opportunity for investors to buy in expectation of a pick-up in growth in FY26.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Sector

A woman wearing headphones looks delighted and animated on news she's receiving from her mobile phone that she is holding close to her face.
Communication Shares

Superloop versus Aussie Broadband shares: Buy, sell or hold?

There is one winner among the two telcos.

Read more »

A man walks dejectedly with his belongings in a cardboard box against a background of office-style venetian blinds as though he has been giving his marching orders from his place of employment.
Technology Shares

What on earth is going on with Xero shares?

Xero shares have tumbled 40%, leaving investors wondering what on earth is going on with the once high-flying tech favourite.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A gloved hand holds lumps of silver against a background of dirt as if at a mine site.
Resources Shares

Which Aussie silver company's shares are charging higher on positive news?

This company says the high silver price is changing the game for its South Australian silver project.

Read more »

A man looks a little perplexed as he holds his hand to his head as if thinking about something as he stands in the aisle of a supermarket.
Consumer Staples & Discretionary Shares

With rising costs, are Woolworths shares still a good buy today?

A leading investment expert offers his outlook for Woolworths shares.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

a line up of job interview candidates sit in chairs against a wall clutching CVs on paper in an office setting.
Communication Shares

Seek shares tipped to storm 45% higher next year: Here's why

Macquarie shares its view on the latest employment report for November.

Read more »